Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2014

Sep 13, 2014

30786_dirs_2014-09-12_23e24af1-3aff-4ffb-9e02-c69384395bcc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2014-09-10

Reporting Person: GOETZ JOHN (EVP, Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-09-11 Bio-Rad A Common Stock M 300 Acquired 48106.7117 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-09-10 Restricted Stock Units $0 A 6000 Acquired Bio-Rad A Common Stock (6000) Direct
2014-09-10 Non-Qualified Stock Option (right to buy) $119.54 A 6000 Acquired 2024-09-10 Bio-Rad A Common Stock (6000) Direct
2014-09-11 Restricted Stock Units $0 M 300 Disposed Bio-Rad A Common Stock (300) Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.

F4: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.

F5: The restricted stock units vest in five equal annual installments beginning September 11, 2014.